Market capitalization | DKK34.68b |
Enterprise Value | DKK34.76b |
P/E (TTM) P/E ratio | 77.06 |
EV/FCF (TTM) EV/FCF | 40.94 |
EV/Sales (TTM) EV/Sales | 6.60 |
P/S ratio (TTM) P/S ratio | 6.59 |
P/B ratio (TTM) P/B ratio | 6.03 |
Revenue growth (TTM) Revenue growth | 12.48% |
Revenue (TTM) Revenue | DKK5.26b |
As a Free StocksGuide user, you can view scores for all 6,901 stocks worldwide.
9 Analysts have issued a Ambu forecast:
9 Analysts have issued a Ambu forecast:
Jun '24 |
+/-
%
|
||
Revenue | 5,263 5,263 |
12%
12%
|
|
Gross Profit | 3,049 3,049 |
15%
15%
|
|
EBITDA | 963 963 |
64%
64%
|
EBIT (Operating Income) EBIT | 595 595 |
201%
201%
|
Net Profit | 450 450 |
1,171%
1,171%
|
In millions DKK.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Ambu A/S engages in the development, production, and marketing of diagnostic and life-supporting devices for hospitals and rescue services. It operates through the following segments: Anaesthesia; Patient Monitoring & Diagnostics; and Visualisation. The Anaesthesia segment offers products from resuscitators, face masks, and laryngeal masks to the single use flexible intubation scope. The Patient Monitoring & Diagnostics segmet provides electrodes for cardiology, neurophysiology, and polysomnography. The Visualisation segment includes single-use visualisation devices, which are used in single lung ventilation procedure, or a bedside bronchoscopy procedure in the intensive care unit . The company was founded by Holger Hesse in 1937 and is headquartered in Ballerup, Denmark.
Head office | Denmark |
CEO | Britt Jensen |
Employees | 4,616 |
Founded | 1937 |
Website | www.ambu.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.